A 20-month-old boy was admitted to the paediatric ward after presenting to casualty with a large burn on the right pectoral area (figure). He was the product of a normal pregnancy and there was no history of note except a head injury sustained at 15 months. There was no history of allergy. He came from an unstable family background, the mother being unmarried and cohabiting with a man who was not his father.
In the early hours of the morning of admission he had woken screaming, having previously been well. Six hours later a general practitioner had been called to see the child but had found no reason for his behaviour. During the subsequent 10 hours an area of erythema 14 x 8 cm, including a central area of blistering with bullae formation, developed on the right chest wall. He presented in the accident and emergency department and was admitted. 
Case reports
Severe pruritus developed in four healthy male donors (including three of us) shortly after they had given granulocytes on an IBM cell separator. The cases occurred at three different centres over a four-month period. As part of the procedure the donors received hetastarch as a 6% solution (Plasmasteril). One donor received one litre over two successive days, the others two litres over seven days; all donated granulocytes on two or three occasions. Two of the donors received hydrocortisone 200 mg intravenously immediately before donation. None had a history of allergy.
The donors developed itching some two weeks after the procedure. The itching was generalised or worse in the perineal region. It was exacerbated by warm water, exercise, scratching, or rubbing with towels. Cold water and cool lotions were soothing. The itching was extremely uncomfortable and socially embarrassing. There were no visible skin changes, and the itching subsided slowly over three to six months. One donor subsequently received a further 500 ml infusion of hetastarch when donating granulocytes but experienced only a short-lived and less severe recurrence of symptoms. At the time of this donation, six months after the initial occasion, the itching had settled and the association with leucapheresis had not been made.
Comment
Sedimenting agents increase the yield of granulocytes, and hetastarch seemed particularly suited for this purpose because it was thought not to be antigenic in man.' Few major problems have been associated with its use, although a case of lichen planus was recently reported in a donor exposed to it.2
We believe that the hetastarch used during leucapheresis was responsible for the itching in our cases. We recognise that other causes-for example, leaching of plasticisers from the equipmentare possible, but they are less likely since itching has occurred only after granulocyte collection and has not affected patients receiving regular plasma exchanges without hetastarch.
Hetastarch is excreted by the kidneys and is also taken up into the reticuloendothelial system. It is an alarmingly persistent substance
